Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression.

Neff CD, Abkevich V, Packer JC, Chen Y, Potter J, Riley R, Davenport C, DeGrado Warren J, Jammulapati S, Bhathena A, Choi WS, Kroeger PE, Metzger RE, Gutin A, Skolnick MH, Shattuck D, Katz DA.

Mol Psychiatry. 2009 Jun;14(6):621-30. doi: 10.1038/mp.2008.8. Epub 2008 Feb 12.

PMID:
18268499
2.

Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis.

Steer S, Abkevich V, Gutin A, Cordell HJ, Gendall KL, Merriman ME, Rodger RA, Rowley KA, Chapman P, Gow P, Harrison AA, Highton J, Jones PB, O'Donnell J, Stamp L, Fitzgerald L, Iliev D, Kouzmine A, Tran T, Skolnick MH, Timms KM, Lanchbury JS, Merriman TR.

Genes Immun. 2007 Jan;8(1):57-68. Epub 2006 Dec 7.

PMID:
17159887
3.

TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition.

Stone S, Abkevich V, Russell DL, Riley R, Timms K, Tran T, Trem D, Frank D, Jammulapati S, Neff CD, Iliev D, Gress R, He G, Frech GC, Adams TD, Skolnick MH, Lanchbury JS, Gutin A, Hunt SC, Shattuck D.

Hum Mol Genet. 2006 Sep 15;15(18):2709-20. Epub 2006 Aug 7.

PMID:
16893906
4.

Variants in Apaf-1 segregating with major depression promote apoptosome function.

Harlan J, Chen Y, Gubbins E, Mueller R, Roch JM, Walter K, Lake M, Olsen T, Metzger P, Dorwin S, Ladror U, Egan DA, Severin J, Johnson RW, Holzman TF, Voelp K, Davenport C, Beck A, Potter J, Gopalakrishnan M, Hahn A, Spear BB, Halbert DN, Sullivan JP, Abkevich V, Neff CD, Skolnick MH, Shattuck D, Katz DA.

Mol Psychiatry. 2006 Jan;11(1):76-85.

PMID:
16231040
5.

Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders.

Camp NJ, Lowry MR, Richards RL, Plenk AM, Carter C, Hensel CH, Abkevich V, Skolnick MH, Shattuck D, Rowe KG, Hughes DC, Cannon-Albright LA.

Am J Med Genet B Neuropsychiatr Genet. 2005 May 5;135B(1):85-93.

PMID:
15806581
6.

Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.

Abkevich V, Zharkikh A, Deffenbaugh AM, Frank D, Chen Y, Shattuck D, Skolnick MH, Gutin A, Tavtigian SV.

J Med Genet. 2004 Jul;41(7):492-507.

7.

A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree.

Timms KM, Wagner S, Samuels ME, Forbey K, Goldfine H, Jammulapati S, Skolnick MH, Hopkins PN, Hunt SC, Shattuck DM.

Hum Genet. 2004 Mar;114(4):349-53. Epub 2004 Jan 15.

PMID:
14727179
8.

Predisposition locus for major depression at chromosome 12q22-12q23.2.

Abkevich V, Camp NJ, Hensel CH, Neff CD, Russell DL, Hughes DC, Plenk AM, Lowry MR, Richards RL, Carter C, Frech GC, Stone S, Rowe K, Chau CA, Cortado K, Hunt A, Luce K, O'Neil G, Poarch J, Potter J, Poulsen GH, Saxton H, Bernat-Sestak M, Thompson V, Gutin A, Skolnick MH, Shattuck D, Cannon-Albright L.

Am J Hum Genet. 2003 Dec;73(6):1271-81. Epub 2003 Nov 5.

9.

Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.

Fujiwara H, Emi M, Nagai H, Nishimura T, Konishi N, Kubota Y, Ichikawa T, Takahashi S, Shuin T, Habuchi T, Ogawa O, Inoue K, Skolnick MH, Swensen J, Camp NJ, Tavtigian SV.

J Hum Genet. 2002;47(12):641-8.

PMID:
12522685
10.

A major predisposition locus for severe obesity, at 4p15-p14.

Stone S, Abkevich V, Hunt SC, Gutin A, Russell DL, Neff CD, Riley R, Frech GC, Hensel CH, Jammulapati S, Potter J, Sexton D, Tran T, Gibbs D, Iliev D, Gress R, Bloomquist B, Amatruda J, Rae PM, Adams TD, Skolnick MH, Shattuck D.

Am J Hum Genet. 2002 Jun;70(6):1459-68. Epub 2002 Apr 15.

11.

Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides.

Samuels ME, Forbey KC, Reid JE, Abkevich V, Bulka K, Wardell BR, Bowen BR, Hopkins PN, Hunt SC, Ballinger DG, Skolnick MH, Wagner S.

Clin Genet. 2001 Feb;59(2):88-98.

PMID:
11260209
12.

A candidate prostate cancer susceptibility gene at chromosome 17p.

Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA.

Nat Genet. 2001 Feb;27(2):172-80.

PMID:
11175785
13.

Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers.

Verhagen PC, Zhu XL, Rohr LR, Cannon-Albright LA, Tavtigian SV, Skolnick MH, Brothman AR.

Cancer Genet Cytogenet. 2000 Oct 1;122(1):43-8.

PMID:
11104032
14.

Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred.

Hunt SC, Hopkins PN, Bulka K, McDermott MT, Thorne TL, Wardell BB, Bowen BR, Ballinger DG, Skolnick MH, Samuels ME.

Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1089-93.

PMID:
10764678
15.

The future of DNA diagnostics.

Skolnick MH.

Dis Markers. 1999 Oct;15(1-3):106-7. No abstract available.

16.

Familial associations between cancer sites.

Thomas A, Cannon-Albright L, Bansal A, Skolnick MH.

Comput Biomed Res. 1999 Dec;32(6):517-29.

PMID:
10587469
17.

Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees.

Neuhausen SL, Farnham JM, Kort E, Tavtigian SV, Skolnick MH, Cannon-Albright LA.

Hum Mol Genet. 1999 Dec;8(13):2437-42.

PMID:
10556291
18.

Testing for hereditary cancer risk: Pandora or Prometheus?

Frank TS, Skolnick MH.

J Clin Endocrinol Metab. 1999 Jun;84(6):1882-5. Review. No abstract available.

PMID:
10372680
19.

Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family.

Swensen J, Hoffman M, Skolnick MH, Neuhausen SL.

Hum Mol Genet. 1997 Sep;6(9):1513-7.

PMID:
9285788
20.

Genetic susceptibility to breast and ovarian cancer.

Skolnick MH, Frank T, Shattuck-Eidens D, Tavtigian S.

Pathol Biol (Paris). 1997 Mar;45(3):245-9. Review.

PMID:
9296070
21.

Familial prostate cancer studies in Utah.

Neuhausen SL, Skolnick MH, Cannon-Albright L.

Br J Urol. 1997 Mar;79 Suppl 1:15-20. No abstract available.

PMID:
9088268
22.

BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.

Caligo MA, Ghimenti C, Cipollini G, Ricci S, Brunetti I, Marchetti V, Olsen R, Neuhausen S, Shattuck-Eidens D, Conte PF, Skolnick MH, Bevilacqua G.

Oncogene. 1996 Oct 3;13(7):1483-8.

PMID:
8875986
23.

Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.

Durocher F, Shattuck-Eidens D, McClure M, Labrie F, Skolnick MH, Goldgar DE, Simard J.

Hum Mol Genet. 1996 Jun;5(6):835-42.

PMID:
8776600
24.

Low incidence of BRCA2 mutations in breast carcinoma and other cancers.

Teng DH, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanwar S, Swedlund B, Wong AK, Kamb A.

Nat Genet. 1996 Jun;13(2):241-4.

PMID:
8640236
25.

Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia.

Meyer LJ, Piepkorn M, Goldgar DE, Lewis CM, Cannon-Albright LA, Zone JJ, Skolnick MH.

J Am Acad Dermatol. 1996 Apr;34(4):618-25.

PMID:
8601651
26.

Genetic heterogeneity and unmapped genes for colorectal cancer.

Lewis CM, Neuhausen SL, Daley D, Black FJ, Swensen J, Burt RW, Cannon-Albright LA, Skolnick MH.

Cancer Res. 1996 Mar 15;56(6):1382-8.

27.

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swense J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AK, Shizuya H, Eyfjord JE, Cannon-Albright L, Tranchant M, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE.

Nat Genet. 1996 Mar;12(3):333-7.

PMID:
8589730
28.

THe genetics of familial breast cancer.

Cannon-Albright LA, Skolnick MH.

Semin Oncol. 1996 Feb;23(1 Suppl 2):1-5. Review.

PMID:
8614840
29.

Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King MC, Goldgar DE.

Am J Hum Genet. 1996 Feb;58(2):271-80.

30.

Identification of the BRCA1 breast cancer gene and its clinical implications.

Kamb A, Skolnick MH.

Important Adv Oncol. 1996:23-35. Review. No abstract available.

PMID:
8791126
31.

Mutations in the BRCA1 gene in Japanese breast cancer patients.

Katagiri T, Emi M, Ito I, Kobayashi K, Yoshimoto M, Iwase T, Kasumi F, Miki Y, Skolnick MH, Nakamura Y.

Hum Mutat. 1996;7(4):334-9.

PMID:
8723683
32.

CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.

Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK, et al.

Oncogene. 1995 Dec 7;11(11):2455. No abstract available.

PMID:
8570198
33.

Monitoring the efficacy of hybrid selection during positional cloning: the search for BRCA1.

Hattier T, Bell R, Shaffer D, Stone S, Phelps RS, Tavtigian SV, Skolnick MH, Shattuck-Eidens D, Kamb A.

Mamm Genome. 1995 Dec;6(12):873-9.

PMID:
8747927
34.

Effects of age, sex steroids, and family relationships on volumes of prostate zones in men with and without prostate cancer.

Meikle AW, Stephenson RA, McWhorter WP, Skolnick MH, Middleton RG.

Prostate. 1995 May;26(5):253-9.

PMID:
7753710
35.

Software trapping: a strategy for finding genes in large genomic regions.

Kamb A, Wang C, Thomas A, DeHoff BS, Norris FH, Richardson K, Rine J, Skolnick MH, Rosteck PR Jr.

Comput Biomed Res. 1995 Apr;28(2):140-53.

PMID:
7656550
36.

CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.

Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK, et al.

Oncogene. 1995 Mar 16;10(6):1061-7. Erratum in: Oncogene. 1995 Dec 7;11(11):2455.

PMID:
7700630
37.

Reconstructing phylogeny from the multifractal spectrum of mitochondrial DNA.

Glazier JA, Raghavachari S, Berthelsen CL, Skolnick MH.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1995 Mar;51(3):2665-2668. No abstract available.

PMID:
9962935
38.

A physical map encompassing GP2B, EPB3, D17S183, D17S78, D17S1183, and D17S1184.

Miki Y, Swensen JJ, Hobbs MR, DeHoff BS, Rosteck PR, Skolnick MH, Neuhausen SL.

Genomics. 1995 Jan 1;25(1):295-7.

PMID:
7774935
39.

Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM).

Cannon-Albright LA, Meyer LJ, Goldgar DE, Lewis CM, McWhorter WP, Jost M, Harrison D, Anderson DE, Zone JJ, Skolnick MH.

Cancer Res. 1994 Dec 1;54(23):6041-4.

40.

Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.

Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH.

J Natl Cancer Inst. 1994 Nov 2;86(21):1600-8.

PMID:
7932824
41.

Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas.

Weaver-Feldhaus J, Gruis NA, Neuhausen S, Le Paslier D, Stockert E, Skolnick MH, Kamb A.

Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7563-7.

42.

Response.

Kamb A, Liu Q, Harshman K, Tavtigian S, Cordon-Cardo C, Skolnick MH.

Science. 1994 Jul 15;265(5170):416-7. No abstract available.

PMID:
17838044
43.

Familiality of cancer in Utah.

Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter WP, Skolnick MH.

Cancer Res. 1994 May 1;54(9):2378-85.

44.

A cell cycle regulator potentially involved in genesis of many tumor types.

Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Skolnick MH.

Science. 1994 Apr 15;264(5157):436-40.

PMID:
8153634
45.

A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis.

Goldgar DE, Fields P, Lewis CM, Tran TD, Cannon-Albright LA, Ward JH, Swensen J, Skolnick MH.

J Natl Cancer Inst. 1994 Feb 2;86(3):200-9.

PMID:
8283492
46.

Genomic mismatch scanning in pedigrees.

Thomas A, Skolnick MH, Lewis CM.

IMA J Math Appl Med Biol. 1994;11(1):1-16.

PMID:
8057038
47.

Transcranial electrostimulation effects on rat opioid and neurotransmitter levels.

Warner RL, Johnston C, Hamilton R, Skolnick MH, Wilson OB.

Life Sci. 1994;54(7):481-90.

PMID:
7906003
48.

A probabilistic model for detecting coding regions in DNA sequences.

Thomas A, Skolnick MH.

IMA J Math Appl Med Biol. 1994;11(3):149-60.

PMID:
7822887
49.

Genetic predisposition to melanoma.

Skolnick MH, Cannon-Albright LA, Kamb A.

Eur J Cancer. 1994;30A(13):1991-5. Review. No abstract available.

PMID:
7734213
50.

Chromosome 17q linkage studies of 18 Utah breast cancer kindreds.

Goldgar DE, Cannon-Albright LA, Oliphant A, Ward JH, Linker G, Swensen J, Tran TD, Fields P, Uharriet P, Skolnick MH.

Am J Hum Genet. 1993 Apr;52(4):743-8.

Supplemental Content

Loading ...
Support Center